Maxlinear Inc
F:JMX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Maxlinear Inc
F:JMX
|
US |
|
T
|
Tenet Healthcare Corp
SWB:THC1
|
US |
|
B
|
Bridgestone Corp
OTC:BRDCF
|
JP |
|
D
|
Diageo PLC
OTC:DGEAF
|
UK |
|
Ems Chemie Holding AG
OTC:EMSHF
|
CH |
|
T
|
TotalEnergies SE
XMUN:TOTB
|
FR |
|
B
|
Baxter International Inc
F:BTL
|
US |
|
Safran SA
PAR:SAF
|
FR |
|
Mitsubishi Electric Corp
TSE:6503
|
JP |
|
D
|
Dover Corp
XMUN:DOV
|
US |
|
S
|
SoftBank Group Corp
F:SFT
|
JP |
|
B
|
BAE Systems PLC
F:BSP
|
UK |
|
M
|
Morgan Stanley
SWB:DWD
|
US |
|
T
|
Tinc NV
F:5TI
|
BE |
|
BAE Systems PLC
OTC:BAESY
|
UK |
|
D
|
Dentsu Group Inc
XMUN:DEN
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is JMX's stock price target?
Price Target
20.6
EUR
According to Wall Street analysts, the average 1-year price target for
JMX is 20.6 EUR with a low forecast of 15.3 EUR and a high forecast of 26.51 EUR.
What is the Revenue forecast for Maxlinear Inc?
Projected CAGR
36%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 36%.
What is the Gross Profit forecast for Maxlinear Inc?
Projected CAGR
36%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 36%.